President Donald Trump has withdrawn America from the World Health Organization. Since then, some believe the WHO has found ...

Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

A targeted therapy called sevabertinib has been approved for patients with non-small cell lung cancer that carries an ...

Success is no longer just about prolonging survival, but about enabling patients to live well after cancer, with fewer long-term toxicities and greater quality of life. This shift reflects both ...

Mayo Clinic researchers say they have discovered that ovarian cancer cells can quickly activate a survival response after treatment with PARP inhibitors.

Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.

As if battling cancer wasn’t difficult enough, many patients lose their hair — especially if they are undergoing chemotherapy ...

A new study links ultra-processed foods after cancer diagnosis to lower survival. Learn why diet matters during recovery and ...

ODESSA, Texas (KMID/KPEJ)- “The most common cancer in pediatric patients is leukemia,” said Dr. Maurizio Ghisoli with Texas ...